Acquired Genetic and Epigenetic Variation in Human Pluripotent Stem Cells
Authors:
- 26 October 2017
- book chapter
- Published by Springer Nature
- Vol. 163, 187-206
Abstract
Human pluripotent stem cells (hPSCs) can acquire non-random genomic variation during culture. Some of these changes are common in tumours and confer a selective growth advantage in culture. Additionally, there is evidence that reprogramming of human induced pluripotent stem cells (hiPSCs) introduces mutations. This poses a challenge to both the safety of clinical applications and the reliability of basic research using hPSCs carrying genomic variation. A number of methods are available for monitoring the genomic integrity of hPSCs, and a balance between practicality and sensitivity must be considered in choosing the appropriate methods for each use of hPSCs. Adjusting protocols by which hPSCs are derived and cultured is an evolving process that is important in minimising acquired genomic variation. Assessing genetic variation for its potential impact is becoming increasingly important as techniques to detect genome-wide variation improve.Keywords
This publication has 60 references indexed in Scilit:
- Normal Human Pluripotent Stem Cell Lines Exhibit Pervasive Mosaic AneuploidyPLOS ONE, 2011
- Modelling the long QT syndrome with induced pluripotent stem cellsNature, 2011
- Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming FactorsCell, 2009
- Induced Pluripotent Stem Cell Lines Derived from Human Somatic CellsScience, 2007
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Constitutional Aneuploidy in the Normal Human BrainThe Journal of Neuroscience, 2005
- Derivation of midbrain dopamine neurons from human embryonic stem cellsProceedings of the National Academy of Sciences, 2004
- Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cellsNature Biotechnology, 2003
- From teratocarcinomas to embryonic stem cellsPhilosophical Transactions of the Royal Society B: Biological Sciences, 2002
- Embryonic Stem Cell Lines Derived from Human BlastocystsScience, 1998